Boston Scientific Corporation (BSX) Earnings History
Annual and quarterly earnings data from 1991 to 2025
Loading earnings history...
BSX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
BSX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 69.0% | 19.8% | 14.4% |
| 2024 | 61.3% | 15.7% | 11.1% |
| 2023 | 62.0% | 15.3% | 11.2% |
| 2022 | 60.8% | 14.4% | 5.5% |
| 2021 | 62.8% | 16.2% | 8.7% |
Download Data
Export BSX earnings history in CSV or JSON format
Free sign-in required to download data
Boston Scientific Corporation (BSX) Earnings Overview
As of May 8, 2026, Boston Scientific Corporation (BSX) reported trailing twelve-month net income of $2.89B, reflecting +55.2% year-over-year growth. The company earned $1.93 per diluted share over the past four quarters, with a net profit margin of 14.4%.
Looking at the long-term picture, BSX's historical earnings data spans multiple years. The company achieved its highest annual net income of $4.70B in fiscal 2019.
Boston Scientific Corporation maintains positive profitability with a gross margin of 69.0%, operating margin of 19.8%, and net margin of 14.4%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including MDT ($4.61B net income, 13.9% margin), EW ($1.07B net income, 17.7% margin), SYK ($3.25B net income, 12.9% margin), BSX has outperformed on profitability metrics. Compare BSX vs MDT →
BSX Earnings vs Peers
Earnings metrics vs comparable public companies
BSX Historical Earnings Data (1991–2025)
35 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $2.89B | +55.7% | $3.97B | $1.94 | 14.4% | 19.8% |
| 2024 | $1.85B | +16.4% | $2.63B | $1.25 | 11.1% | 15.7% |
| 2023 | $1.59B | +128.2% | $2.18B | $1.07 | 11.2% | 15.3% |
| 2022 | $698M | -32.9% | $1.82B | $0.45 | 5.5% | 14.4% |
| 2021 | $1.04B | +1368.3% | $1.92B | $0.69 | 8.7% | 16.2% |
| 2020 | -$82M | -101.7% | $601M | $-0.08 | -0.8% | 6.1% |
| 2019 | $4.70B | +181.3% | $1.71B | $3.33 | 43.8% | 15.9% |
| 2018 | $1.67B | +1506.7% | $1.74B | $1.19 | 17.0% | 17.7% |
| 2017 | $104M | -70.0% | $1.52B | $0.07 | 1.1% | 16.9% |
| 2016 | $347M | +245.2% | $1.24B | $0.25 | 4.1% | 14.7% |
Full BSX Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See BSX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BSX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BSX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBSX — Frequently Asked Questions
Quick answers to the most common questions about buying BSX stock.
Is BSX growing earnings?
BSX EPS is $1.93, with earnings growth accelerating to +55.2%. This exceeds the 5-year CAGR of N/A. TTM net income reached $2.9B.
What are BSX's profit margins?
Boston Scientific Corporation net margin is +14.4%, with operating margin at +19.8%. Margins sit within typical range for the sector.
How consistent are BSX's earnings?
BSX earnings data spans 1991-2025. The accelerating earnings trend is +55.2% YoY. Historical data enables comparison across business cycles.